Filter
352
Filtered Results: 352
Text search:
National
Drug
Authority,
Uganda
Featured
Recommendations
29
New Publications
119
Language
Document type
No document type
208
Studies & Reports
75
Guidelines
35
Strategic & Response Plan
15
Manuals
9
Fact sheets
5
Situation Updates
3
Training Material
2
Countries / Regions
Uganda
68
Kenya
26
Malawi
12
Tanzania
12
Ethiopia
12
Global
11
Nigeria
9
South Africa
9
Zambia
9
Ghana
8
Rwanda
8
Congo, Democratic Republic of
8
Liberia
8
Sierra Leone
7
Africa
6
Namibia
4
Zimbabwe
3
Guinea
3
Syria
2
Iran
2
Senegal
2
Jordan
2
Sudan
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Mexico
1
Lesotho
1
Benin
1
Cameroon
1
Albania
1
Laos
1
Burkina Faso
1
Morocco
1
Philippines
1
Haiti
1
Cambodia
1
Venezuela
1
Latin America and the Carribbean
1
Germany
1
Saudi Arabia
1
West and Central Africa
1
Western and Central Europe
1
Gabon
1
Tunisia
1
Lebanon
1
Sri Lanka
1
Greece
1
Georgia
1
Central African Republic
1
Botswana
1
South Sudan
1
Iraq
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Countries
155
Clinical Guidelines
31
Public Health
18
Women & Child Health
15
Key Resources
10
Pharmacy & Technologies
10
Capacity Building
4
Toolboxes
HIV
45
AMR
35
Mental Health
25
Pharmacy
20
TB
16
NTDs
12
Ebola & Marburg
10
Rapid Response
9
Refugee
9
COVID-19
7
Planetary Health
7
Caregiver
6
NCDs
6
Disability
4
Conflict
4
Global Health Education
3
Cholera
2
Health Financing Toolbox
2
Zika
2
Natural Hazards
1
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
Networking for Policy Change: TB/HIV Participant’s Guide
WHO/HTM/TB/2007.384b
“TB is too often a death sentence for people with AIDS. It does not have to be this
way.”
-Nelson Mandela, International conference on HIV and AIDS, Bangkok, Thailand, July 2004.
The Kenyan Health Sector has been playing a critical role in
providing health care services in response to the population
needs in line with the Kenya Health Policy, 2014-2030’s goal
of attaining the highest possible health standards in a manner
responsive to the population needs.
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
Health, Rights and Drugs
recommended
Harm Reducation, Decriminalization and Zero Discrimination for People who use Drugs
A feasibility study in five African sites
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate ...
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
Project Paper to provide an additional grant for: Human Development Systems Strengthening Project (HDSSP)(P145965, H9360)
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
